Bio-Rad Laboratories Inc (BIO) has a current stock price of $284.6. During the previous trading session, the stock witnessed a notable rise, reaching a high of $409.0 after opening at $284.6. The stock’s low for the day was $265.0, and it eventually closed at $241.95.
Bio-Rad Laboratories Inc’s stock has had a tumultuous market performance.
52-week price history of BIO Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Bio-Rad Laboratories Inc’s current trading price is -26.65% away from its 52-week high, while its distance from the 52-week low is 34.61%. The stock’s price range during this period has fluctuated between $211.43 and $387.99. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.11 million for the day, which was evidently higher than the average daily volume of 0.36 million over the last three months.
Financial Performance and Market Capitalization
Bio-Rad Laboratories Inc (BIO) has experienced a quarterly rise of 18.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.48B and boasts a workforce of 7700 employees.
Analysts’ Ratings For Bio-Rad Laboratories Inc
As of right now, 2 analysts are rating Bio-Rad Laboratories Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 242.38, with a change in price of +36.84. Similarly, Bio-Rad Laboratories Inc recorded 376,174 in trading volume during the last 100 days, posting a change of +14.87%.
BIO Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BIO stands at 0.20. Similarly, the long-term debt-to-equity ratio is also 0.19.
BIO Stock Stochastic Average
The raw stochastic average for Bio-Rad Laboratories Inc over the last 50 days is presently at 90.97%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 86.60%. Further, the company’s Stochastic %K and %D values for the last 20 days were 47.59% and 43.68%, respectively.
BIO Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price loss of -16.35% this year. Over the last six months, there has been a stronger performance of -20.69%. The price of BIO fallen by 13.54% during the last 30 days period. For the last 5-days stocks have improved 7.73%.
